Literature DB >> 21802839

Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk.

Scott M Langevin1, Jennifer R Grandis, Emanuela Taioli.   

Abstract

Men are much more likely than women to develop head and neck squamous cell carcinoma (HNSCC), a discrepancy that is insufficiently explained by gender differences in smoking and alcohol consumption. It has been hypothesized that differential hormonal exposures may account for some of this risk but thus far the literature on female reproductive factors and HNSCC risk has been sparse. To address the association of HNSCC with female hormonal and reproductive factors, a case-control study was conducted on 149 women with head and neck cancer and 158 controls. After adjusting for potential confounding, postmenopausal women using female hormones for more than 5 years showed a borderline protective effect for HNSCC (adjusted OR = 0.47, 95% CI: 0.20-1.08), with a borderline trend across duration of use categories (P = 0.06). There was no association of HNSCC with age at menarche, hysterectomy/oophorectomy status, oral contraceptive use, history of fertility medication, or number of pregnancies, parity, or age at first pregnancy or live birth. The findings of this study do not support a link between HNSCC and reproductive factors, although the borderline association with HRT warrants further investigation.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802839      PMCID: PMC3169650          DOI: 10.1016/j.canlet.2011.07.007

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  31 in total

Review 1.  The impact of hormonal fluctuations on female vocal folds.

Authors:  Ofer Amir; Tal Biron-Shental
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2004-06       Impact factor: 2.064

2.  A comparative study of prescribing of hormone replacement therapy in USA and Europe.

Authors:  J V Jolleys; F Olesen
Journal:  Maturitas       Date:  1996-02       Impact factor: 4.342

Review 3.  Sex hormones and the female voice.

Authors:  J Abitbol; P Abitbol; B Abitbol
Journal:  J Voice       Date:  1999-09       Impact factor: 2.009

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen.

Authors:  Yoko Omoto; Otabek Imamov; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

6.  Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.

Authors:  André Lopes Carvalho; Inês Nobuko Nishimoto; Joseph A Califano; Luiz Paulo Kowalski
Journal:  Int J Cancer       Date:  2005-05-01       Impact factor: 7.396

7.  Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate.

Authors:  Otabek Imamov; Andrea Morani; Gil-Jin Shim; Yoko Omoto; Christina Thulin-Andersson; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-08       Impact factor: 11.205

8.  Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands.

Authors:  H Välimaa; S Savolainen; T Soukka; P Silvoniemi; S Mäkelä; H Kujari; J-A Gustafsson; M Laine
Journal:  J Endocrinol       Date:  2004-01       Impact factor: 4.286

9.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence.

Authors:  Adam L Hersh; Marcia L Stefanick; Randall S Stafford
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

10.  Role of estrogen receptor beta in colonic epithelium.

Authors:  Osamu Wada-Hiraike; Otabek Imamov; Haruko Hiraike; Kjell Hultenby; Thomas Schwend; Yoko Omoto; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

View more
  6 in total

1.  Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Ching Ying Lin; Hyunwoo Kwon; Guillermo O Rangel Rivera; Xue Li; Dongjun Chung; Zihai Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-26       Impact factor: 4.254

Review 2.  Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer.

Authors:  Sonia N Whang; Maria Filippova; Penelope Duerksen-Hughes
Journal:  Viruses       Date:  2015-09-17       Impact factor: 5.048

3.  Hormone factors play a favorable role in female head and neck cancer risk.

Authors:  Dana Hashim; Samantha Sartori; Carlo La Vecchia; Diego Serraino; Luigino Dal Maso; Eva Negri; Elaine Smith; Fabio Levi; Stefania Boccia; Gabriella Cadoni; Hung N Luu; Yuan-Chin Amy Lee; Mia Hashibe; Paolo Boffetta
Journal:  Cancer Med       Date:  2017-07-14       Impact factor: 4.452

4.  Relationship between Menopausal Hormone Therapy and Oral Cancer: A Cohort Study Based on the Health Insurance Database in South Korea.

Authors:  Jin-Sung Yuk; Bo Young Kim
Journal:  J Clin Med       Date:  2022-10-02       Impact factor: 4.964

Review 5.  Human papillomavirus induced transformation in cervical and head and neck cancers.

Authors:  Allie K Adams; Trisha M Wise-Draper; Susanne I Wells
Journal:  Cancers (Basel)       Date:  2014-09-15       Impact factor: 6.639

6.  Correlation of CD133 and Oct-4 expression with clinicopathological and demographic parameters in oral squamous cell carcinoma patients.

Authors:  Alok Singh; Anand Narain Srivastava; Salman Akhtar; Mohammad Haris Siddiqui; Pooja Singh; Vijay Kumar
Journal:  Natl J Maxillofac Surg       Date:  2018 Jan-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.